Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.15420/icr.2017:3:2 http://scihub22266oqcxt.onion/10.15420/icr.2017:3:2 C5808466!5808466!29588731     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Interv+Cardiol 2017 ; 12 (1): 51-5 Nephropedia Template TP {{tp|p=29588731|t=2017. Management of Tricuspid Regurgitation: The Role of Transcatheter Therapies |pdf=|usr=}}{{29588731}} gab.com Text Management of Tricuspid Regurgitation: The Role of Transcatheter Therapies JO: Interv Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=29588731 #FOAvip Surgical treatment is the gold standard treatment of functional tricuspid regurgitation (FTR) but this carries high risks of morbidity and mortality. Percutaneous procedures are an attractive alternative to surgery for selected patients deemed to be high-risk surgical candidates. A number of tricuspid transcatheter devices have been developed to treat FTR, but at present, evidence of their efficacy and safety is scarce. Preliminary data have shown promising results, but ongoing and future studies will provide a clearer picture of the benefits of these new techniques. Twit Text FOAVip Management of Tricuspid Regurgitation: The Role of Transcatheter Therapies ????Interv Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=29588731 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29588731 #FOAvip English Wikipedia <ref>{{Cite pmid|29588731}}</ref> Management of Tricuspid Regurgitation: The Role of Transcatheter Therapies #MMPMID29588731 Taramasso M; Calen C; Guidotti A; Kuwata S; Biefer HRC; Nietlispach F; Zuber M; Maisano F Interv Cardiol 2017[May]; 12 (1): 51-5 PMID29588731show ga Surgical treatment is the gold standard treatment of functional tricuspid regurgitation (FTR) but this carries high risks of morbidity and mortality. Percutaneous procedures are an attractive alternative to surgery for selected patients deemed to be high-risk surgical candidates. A number of tricuspid transcatheter devices have been developed to treat FTR, but at present, evidence of their efficacy and safety is scarce. Preliminary data have shown promising results, but ongoing and future studies will provide a clearer picture of the benefits of these new techniques. äManagement of Tricuspid Regurgitation: The Role of Transcatheter Thera(epmc).pdf DeepDyve Pubget Overpricing